CXCR4 and familial pancreatic carcinoma: Another study reported this compound to be a novel inhibitor of CXCR4 and thus found to hold immense potential in suppressing metastasis in pancreatic cancer and also in case of breast cancer, the most predominant cancer type among women across the world (Chua et al., 2010; Thakur et al., 2018).